The Zacks Analyst Blog Highlights: Home Depot, Abbott, Bristol-Myers, Activision and Marathon Zacks Equity Research - Zacks Investment Research - Thu Aug 22, 10:23AM CDT Zacks Equity Research - ZACKS - Thu Aug 22, 10:23AM CDT
The Zacks Analyst Blog Highlights: Home Depot, Abbott, Bristol-Myers, Activision and Marathon
Top Stock Reports for Home Depot, Abbott & Bristol-Myers Mark Vickery - Zacks Investment Research - Wed Aug 21, 1:04PM CDT Mark Vickery - ZACKS - Wed Aug 21, 1:04PM CDT
Top Stock Reports for Home Depot, Abbott & Bristol-Myers
The Zacks Analyst Blog Highlights: Walt Disney, AngloGold, Vipshop, Bristol-Myers and Integer Zacks Equity Research - Zacks Investment Research - Wed Aug 21, 11:11AM CDT Zacks Equity Research - ZACKS - Wed Aug 21, 11:11AM CDT
The Zacks Analyst Blog Highlights: Walt Disney, AngloGold, Vipshop, Bristol-Myers and Integer
The Zacks Analyst Blog Highlights: AngloGold, Bristol-Myers, Delta Air, JD.com and M/I Homes Zacks Equity Research - Zacks Investment Research - Wed Aug 21, 11:01AM CDT Zacks Equity Research - ZACKS - Wed Aug 21, 11:01AM CDT
The Zacks Analyst Blog Highlights: AngloGold, Bristol-Myers, Delta Air, JD.com and M/I Homes
Keloid Treatment Market 2019 Outlook, Opportunity and Demand Analysis Report by 2024 Heraldkeepers - Wed Aug 21, 10:36AM CDT CMTX - Wed Aug 21, 10:36AM CDT
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing...
AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study Zacks Equity Research - Zacks Investment Research - Wed Aug 21, 9:50AM CDT Zacks Equity Research - ZACKS - Wed Aug 21, 9:50AM CDT
AstraZeneca's (AZN) Imfinzi fails to improve overall survival in a study for previously treated stage IV non-small cell lung cancer (NSCLC) patients.
Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector PR Newswire - Wed Aug 21, 7:30AM CDT CMTX - Wed Aug 21, 7:30AM CDT
Biotech and biopharma industry leaders are posting record financials and hitting milestone markers in their research and growth, good indicators of a strong market with potential for robust returns on...
Disney Whistleblower's Time in the Sun Sejuti Banerjea - Zacks Investment Research - Tue Aug 20, 1:40PM CDT Sejuti Banerjea - ZACKS - Tue Aug 20, 1:40PM CDT
Former Disney employee Sandra Kuba says company executives have been overstating revenues.
Exelixis (EXEL) Stock Up 15.2% YTD on Strong Cabometyx Sales Zacks Equity Research - Zacks Investment Research - Tue Aug 20, 9:09AM CDT Zacks Equity Research - ZACKS - Tue Aug 20, 9:09AM CDT
Exelixis (EXEL) continues to fortify its footing in the kidney cancer market on strong Cabometyx performance.
Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your Portfolio Zacks Equity Research - Zacks Investment Research - Tue Aug 20, 8:15AM CDT Zacks Equity Research - ZACKS - Tue Aug 20, 8:15AM CDT
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
4 High Earnings Yield Stocks to Bolster Your Portfolio Zacks Equity Research - Zacks Investment Research - Tue Aug 20, 8:07AM CDT Zacks Equity Research - ZACKS - Tue Aug 20, 8:07AM CDT
Earnings yield is quite effective for determining undervalued stocks.
Recession Fears Ebb on Fresh Wave of Stimulus: 5 Top Gainers Tirthankar Chakraborty - Zacks Investment Research - Tue Aug 20, 7:11AM CDT Tirthankar Chakraborty - ZACKS - Tue Aug 20, 7:11AM CDT
Fears of recession ebb after White House considers tax cuts for millions of workers, China unveils new interest rate reforms and Germany hints at stimulus measures.
Bristol-Myer Sqb Set to Possibly Pullback After Yesterday's Rally of 1.19% Comtex SmarTrend(R) - Mon Aug 19, 12:24PM CDT CMTX - Mon Aug 19, 12:24PM CDT
Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $47.00 to a high of $47.63. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...
Watch for Bristol-Myer Sqb to Potentially Pullback After Gaining 1.19% Yesterday Comtex SmarTrend(R) - Mon Aug 19, 12:24PM CDT CMTX - Mon Aug 19, 12:24PM CDT
Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $47.00 to a high of $47.63. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...
Celgene Gets FDA Approval for Inrebic in Bone Marrow Cancer Zacks Equity Research - Zacks Investment Research - Mon Aug 19, 9:24AM CDT Zacks Equity Research - ZACKS - Mon Aug 19, 9:24AM CDT
Celgene's (CELG) oncology portfolio gets a boost with the FDA approval of Inrebic for rare bone marrow cancer.
Roche Receives FDA Nod for Rozlytrek in ROS1-positive NSCLC Zacks Equity Research - Zacks Investment Research - Fri Aug 16, 8:00AM CDT Zacks Equity Research - ZACKS - Fri Aug 16, 8:00AM CDT
Roche's (RHHBY) lung cancer portfolio gets a boost with the approval of yet another drug, Rozlytrek, for metastatic NSCLC.
Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal GlobeNewswire - Fri Aug 16, 7:24AM CDT CMTX - Fri Aug 16, 7:24AM CDT
- Orbimed, Pontifax and Arkin Holdings to deposit $3.5 million investment in Kitov in escrow
Moleculin Completes Enrollment in Early-Stage Cancer Study Zacks Equity Research - Zacks Investment Research - Thu Aug 15, 6:55AM CDT Zacks Equity Research - ZACKS - Thu Aug 15, 6:55AM CDT
Moleculin (MBRX) reaches enrollment target in a clinical study evaluating its p-STAT3 inhibitor, WP1220, as a treatment for cutaneous T-cell lymphoma, a form of skin cancer.
Merck's Cancer Immunotherapy Keytruda Continues to Aid Growth Zacks Equity Research - Zacks Investment Research - Thu Aug 15, 6:48AM CDT Zacks Equity Research - ZACKS - Thu Aug 15, 6:48AM CDT
Merck's (MRK) Keytruda is rapidly gaining strength as a key contributor to the company's top line. The Keytruda development program is also progressing well.
Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority GlobeNewswire - Wed Aug 14, 7:20AM CDT CMTX - Wed Aug 14, 7:20AM CDT
Israeli Investigation of Kitov and certain officers has been terminated
